Clinical Cardiology
RSSArticles
New Study Calls for Caution in Use of Triple Anticoagulant Therapy
Approximately one in four older patients with atrial fibrillation undergoing percutaneous coronary intervention for acute myocardial infarction were discharged on triple therapy, which was associated with higher rates of major bleeding without a measurable benefit in terms of major adverse cardiac events.
RITA-3 Reports 10-year Mortality Outcomes: Time to Rethink the Guidelines, or Much Ado About Nothing?
The mortality benefit of the routine early invasive strategy seen at 5 years is attenuated at later follow-up, suggesting further trials of more contemporary treatment strategies in non-ST elevation acute coronary syndromes are needed.
Doppler Echo Risk Stratification in Aortic Stenosis
The dimensionless index is an accurate indicator of aortic stenosis severity of clear prognostic value.
Valve Disease and Thromboembolic Risk
ABSTRACT & COMMENTARY: In non-valvular atrial fibrillation patients, left ventricular valve disease increased the risk of thromboembolic events.
Surgery for All Papillary Fibroelastomas?
Patients with papillary fibroelastomas on echo who do not undergo surgical removal have an increased risk of stroke.
When to Repair the Tricuspid Valve with Mitral Surgery
In patients undergoing mitral valve repair with moderate tricuspid regurgitation or tricuspid annular dilatation, tricuspid annuloplasty is safe and is associated with improved long-term right ventricular function.
Two Studies Weaken the Case for Drug-Eluting Balloon Treatment of Coronary In-stent Restenosis
Repeat stenting with drug-eluting stents should, for now, be considered the default treatment for in-stent restenosis.
Refining Stroke Risk Prediction in Heart Failure Without Atrial Fibrillation
ABSTRACT & COMMENTARY: A high-risk subgroup of heart failure patients without atrial fibrillation can be identified using simple clinical variables.
Are Beta-blockers Post-CABG Indicated?
In post-coronary artery bypass graft surgery patients, long-term beta-blocker use was associated with lower rates of death and major adverse cardiac and cerebrovascular events.
Time to Shelve Warfarin for Atrial Fibrillation Patients?
Patients with atrial fibrillation taking oral anticoagulants exhibited a decline in renal function that was greatest with warfarin use vs dabigatran use.